The Dow Jones Industrial Average (INDEX: ^DJI) still can't get over its 4th of July hangover. The blue chips dropped for the sixth day in a row and, unfortunately, it has no plans to rest on the seventh. The Dow declined 31 points today, or 0.25%, but still outperformed the S&P 500 and the Nasdaq, which fell 0.5% and 0.75%, respectively. Over the six-day period, the index has lost about 370 points.
The Fed's indication yesterday that it had no plans for another round of quantitative easing appeared to weigh on the Dow at the open, as it fell about 100 points in early trading. Japan's central bank also passed up an opportunity for monetary relief, further souring investors.
Indian IT giant Infosys (NAS: INFY) became the latest tech company to lower its Q2 earnings projections, adding its name to a list that includes Advanced Micro Devices and Applied Materials, which offered a similar sentiment earlier in the week. In a sign of the market's increasingly gloomy outlook, Bank of America's research wing lowered its S&P 500 earnings forecast by $1.50/share for this year and next.
Despite the market's slide, there was some good news to be found today. Initial unemployment claims fell to four-year lows, dropping by 26,000 to 350,000. The number, which is seasonally adjusted, could be distorted because automakers, who usually temporarily lay off employees at this time of year so they can reconfigure machinery, kept plants open last week due to high demand. Continuing unemployment claims, meanwhile, remained roughly the same.
Two Dow stocks stood head and shoulders above the crowd today. Pharmaceutical-maker Merck (NYS: MRK) jumped more than 4% on news that its osteoporosis drug odanacatib passed an important trial, by demonstrating that it decreases the risk of fracture. The drugmaker has gained about 15% since June 1. Procter & Gamble (NYS: PG) was the other big winner on the day, gaining after word broke that activist investor William Ackman was building a position in the consumer-products giant. The company recently lowered its second-quarter guidance, and reports came out after hours that the board of directors is discussing plans to replace CEO Robert McDonald.
Leading the Dow's march downward were tech components Cisco, Microsoft, and Intel, all falling more than 2% on Infosys's warning.
Finally, keep an eye out for JPMorgan Chase's (NYS: JPM) earnings report tomorrow morning at 7AM. Wall Street is expecting profits of 76 cents per share from the financial giant, down from the $1.21 it projected before the bank's multibillion-dollar trading loss was revealed. Fellow financial Wells Fargo will report its quarter at 8AM, with analysts expecting an EPS of 81 cents. Look for those two reports to dictate the Dow's direction when markets open.
Keep your eye on the ball
During a losing streak like this, it can be easy to want to throw in the towel. Take refuge in some of the newest defensive stock picks from one of our top analysts. He's found three Dow components that stand out from their peers, thanks to a combination of brand recognition, product range, and international growth opportunities. Find out which stocks made this exclusive list in our special free report: "3 Dow Stocks Dividend Investors Need." Just click right here to get your free copy now.
The article Why The Dow's Looking Like Glass Joe originally appeared on Fool.com.
Fool contributorJeremy Bowmanholds no positions In the companies in this article. The Motley Fool owns shares of Bank of America, Cisco Systems, Microsoft, JP Morgan Chase, and Intel. The Fool owns shares of and has created a covered strangle position in Wells Fargo. Motley Fool newsletter services have recommended buying shares of Wells Fargo, Procter & Gamble, Intel, and Microsoft. Motley Fool newsletter services have recommended creating a bull call spread position in Microsoft. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.